Several major global vaccine manufacturers released updates and company news since October 25, 2025, spanning Western, Asian, and African producers. Western Producers Dynavax Technologies (USA): Reported increased revenue from HEPLISAV-B® for Q3 2025 and announced positive Phase 1/2 data for a shingles vaccine candidate. Entered an exclusive license agreement with Vaxart for an oral COVID-19 vaccine and launched a US$100 million share repurchase program. Novavax (USA/EU): Completed the U.S. marketing authorization transfer for Nuvaxovid™ (COVID-19 vaccine) to Sanofi, triggering a US$25 million milestone payment. Announced positive interim results for combination vaccine trials and expanded manufacturing and licensing partnerships, including new approvals in Japan. Asian Producers Serum Institute of India: Announced on October 28, 2025, the creation of the world’s largest Nipah virus vaccine reserve in collaboration with CEPI and Oxford University, aiming for up to 100,000 investigational doses for Phase II trials and emergency use. Africa Vaccine Industrial Company (VIC, Saudi Arabia): Signed a landmark agreement with CSL...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!
